MitoP Cancer Research Results
MitoP, Mitophagy: Click to Expand ⟱
| Source: |
| Type: |
Mitophagy—the selective autophagic removal of damaged mitochondria—is now regarded as a core upstream process in Alzheimer’s disease pathophysiology, not a secondary epiphenomenon. Impairment of mitophagy precedes overt amyloid and tau pathology and helps explain early synaptic failure and neuronal vulnerability.
|
Scientific Papers found: Click to Expand⟱
TRPV2↑, Ca+2↑, MitoP↑, Synergy↑,
| - |
in-vitro, |
neuroblastoma, |
SH-SY5Y |
|
|
|
*toxicity↑, TumCD↑, ROS↑, mtDam↑, Apoptosis↑, MitoP↑, TumAuto↑, p‑Akt↓, p‑mTOR↓, LC3II↑, Beclin-1/ATG6↑, ATG5↑, PINK1↑, PARK2↑, tumCV↓, MDA↑, SOD↑, Catalase↑, eff↓, MMP↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, Cyt‑c↑, Bcl-2↓, proCasp3↓, Bax:Bcl2↑, eff↑, *AntiP↑, *Inflam↓, *AntiDiabetic↑, *AntiViral↑, BBB∅, toxicity↝,
| - |
vitro+vivo, |
neuroblastoma, |
NA |
|
|
|
MMP↓, mtDam↑, ROS↑, PINK1↑, TumCG↓, OS↑, TumAuto↑, MitoP↑,
mtDam↑, Apoptosis↑, MitoP↑, Dose↝, Dose↝, eff↑, PINK1↑, PARK2↑,
tumCV↓, TumCMig↓, TumCI↓, CSCs↓, N-cadherin↓, Snail↓, Zeb1↓, SOX2↓, Nanog↓, OCT4↓, E-cadherin↑, ALDH↓, mtDam↑, MMP↓, compV↓, mt-ROS↑, PINK1↑, PARK2↑, AMPK↑, LC3A↑, LC3B↑, MFN2↓, MitoP↑, Apoptosis↑, Casp3↑, Casp9↑, Cyt‑c↑,
ER Stress↑, UPR↑, autoF↓, lysosome↝, ROS↑, lipid-P↑, CSCs↓, necrosis↑, ATP↓, MMP↓, MOMP↑, DNAdam↑, AIF↑, lysoMP↑, MitoP↑, Ca+2↑,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
T98G |
|
|
|
- |
in-vitro, |
GBM, |
A172 |
|
|
|
TumAuto↑, ROS↑, TumCD↑, tumCV↓, selectivity↑, MMP↓, eff↓, MitoP↑,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↑, 1, lipid-P↑, 1, MDA↑, 1, ROS↑, 4, mt-ROS↑, 1, SOD↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compV↓, 1, MFN2↓, 1, mtDam↑, 4, PINK1↑, 4,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, ATP↓, 1,
Cell Death(tgid=5) ⓘ
AIF↑, 1, Apoptosis↑, 3, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp3↑, 1, cl‑Casp3↑, 1, proCasp3↓, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, MOMP↑, 1, necrosis↑, 1, TumCD↑, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
p‑Akt↓, 1, p‑mTOR↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
OCT4↓, 1, SOX2↓, 1, tumCV↓, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, UPR↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, autoF↓, 1, Beclin-1/ATG6↑, 1, LC3A↑, 1, LC3B↑, 1, LC3II↑, 1, lysoMP↑, 1, lysosome↝, 1, MitoP↑, 7, PARK2↑, 3, TumAuto↑, 3,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, cl‑PARP↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ALDH↓, 1, CSCs↓, 2, Nanog↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 2, E-cadherin↑, 1, N-cadherin↓, 1, Snail↓, 1, TumCI↓, 1, TumCMig↓, 1, Zeb1↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB∅, 1, MMP↓, 5, TRPV2↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 2, eff↓, 2, eff↑, 2, selectivity↑, 1, Synergy↑, 1,
Functional Outcomes(tgid=23) ⓘ
OS↑, 1, toxicity↝, 1,
Total Targets: 67
Pathway results for Effect on Normal Cells:
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, toxicity↑, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiP↑, 1, AntiViral↑, 1,
Total Targets: 5
Scientific Paper Hit Count for: MitoP, Mitophagy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1406 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page